Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03551249
What this trial is testing

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

Who this might be right for
GliomaGlioblastoma
InSightec 20
Testing effectiveness (Phase 2)Study completedNCT00003185
What this trial is testing

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Ended earlyNCT00548938
What this trial is testing

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Who this might be right for
Glioblastoma MultiformeHigh-Grade Glioma
Methodist Healthcare - Memphis 40
Testing effectiveness (Phase 2)Ended earlyNCT01898273
What this trial is testing

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Cellectar Biosciences, Inc. 7
Not applicableLooking for participantsNCT07413796
What this trial is testing

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Who this might be right for
Brain Tumor AdultBrain Tumor BenignMeningioma+2 more
Medical University of Warsaw 382
Testing effectiveness (Phase 2)Looking for participantsNCT04115761
What this trial is testing

Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients

Who this might be right for
GBM
Ever Supreme Bio Technology Co., Ltd. 24
Not applicableStudy completedNCT00561873
What this trial is testing

Nimotuzumab in Children With HGG

Who this might be right for
High Grade Glioma
Oncoscience AG 45
Testing effectiveness (Phase 2)Ended earlyNCT05297864
What this trial is testing

PARP Inhibition for Gliomas (PI-4G or π4g)

Who this might be right for
Recurrent GlioblastomaRecurrent AstrocytomaRecurrent Oligodendroglioma+1 more
University of Oklahoma 15
Testing effectiveness (Phase 2)Ended earlyNCT02340156
What this trial is testing

Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma

Who this might be right for
RECURRENT GLIOBLASTOMA
SynerGene Therapeutics, Inc. 1
Very early researchActive Not RecruitingNCT05023551
What this trial is testing

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Who this might be right for
High Grade GliomaGlioblastoma Multiforme
Sumitomo Pharma America, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT00613093
What this trial is testing

Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Glioma
Duke University 67
Large-scale testing (Phase 3)Study completedNCT00068952
What this trial is testing

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Pfizer 118
Not applicableLooking for participantsNCT05941234
What this trial is testing

Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Testing effectiveness (Phase 2)Ended earlyNCT03119064
What this trial is testing

BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaGBM
Brown University 12
Testing effectiveness (Phase 2)Study completedNCT00005826
What this trial is testing

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 17
Testing effectiveness (Phase 2)Study completedNCT05183204
What this trial is testing

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Who this might be right for
Glioblastoma
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Study completedNCT00541138
What this trial is testing

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT04116658
What this trial is testing

First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma

Who this might be right for
Glioblastoma, Adult
Enterome 100
Testing effectiveness (Phase 2)Study completedNCT03291314
What this trial is testing

Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)
Universitair Ziekenhuis Brussel 52
Early research (Phase 1)Study completedNCT02718443
What this trial is testing

VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

Who this might be right for
Glioblastoma
Vaximm GmbH 14
Next Page